EcoDrugPlus

Leukotriene A4 Hydrolase

Ensembl ID : ENSHCOG00000006998
Gene Symbol: LTA4H
3 Cross references
203 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSHCOG00000019595
Gene Symbol: LTB4R
3 Cross references
142 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSHCOG00000013418
Gene Symbol: LOC109524108
3 Cross references
167 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSHCOG00000013252
Gene Symbol: LOC109516517
3 Cross references
157 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor-Like

Ensembl ID : ENSHCOG00000018243
Gene Symbol: LOC109513361
4 Cross references
200 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSHCOG00000013009
Gene Symbol: KDM1A
3 Cross references
212 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSHCOG00000011737
Gene Symbol: LOC109522198
3 Cross references
209 Possible Orthologues:

Lysyl Oxidase Homolog 2b-Like

Ensembl ID : ENSHCOG00000006573
Gene Symbol: LOC109525047
3 Cross references
213 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSHCOG00000010563
Gene Symbol: MIF
3 Cross references
228 Possible Orthologues:

Macrophage Migration Inhibitory Factor-Like

Ensembl ID : ENSHCOG00000010642
Gene Symbol: LOC109524442
3 Cross references
228 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSHCOG00000010321
Gene Symbol: MST1R
2 Cross references
193 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSHCOG00000000958
Gene Symbol: LOC109510662
2 Cross references
188 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).